Vir Biotechnology, Inc. (VIR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

499 ILLINOIS STREET SAN FRANCISCO, CA 94158

Vir Biotechnology, Inc. operates as a clinical-stage immunology company. The Company develops and commercializes therapeutics and medicines for the treatments and preventions for viral and bacterial diseases. Vir Biotechnology serves customers in the State of California.

Data as of 2020-08-01
Market Cap6.033 Billion Shares Outstanding126.328 Million Avg 30-day Volume1.582 Million
P/E Ratio Dividend Yield EPS-6.24
Price/Sales744.775 Price cash flow ratio Price free cash flow ratio-46.3
Book Value3.01 Price to Tangible Book18.12 Alpha0.22
Short Interest Ratio % Short Interest to Float R-squared0.036401
BETA-1.13684 52-week High/Low75.0 / 11.6504 Stddev0.44773
View SEC Filings from VIR instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 2 1 (0.07%)
13F Filers holding this stock: 60 13 (0.85%)
Aggregate 13F shares on 03/31/2020: 36.198 Million 4.226 Million
Aggregate 13F shares on 12/31/2019: 34.918 Million 4.578 Million
Percent change: 3.67% -7.68%
Funds creating new positions: 28 8
Funds Adding to an existing position: 15 3
Funds closing out their position: 6 3
Funds reducing their position: 10 2
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding VIR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VIR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

259.5 Thousand total shares from 23 transactions

Exercise Derivative Conversion (M)

169.5 Thousand total shares from 16 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PARRISH JAY CHIEF BUSINESS OFFICER

  • Officer
222,222 2020-08-03 5

RICE STEVEN J. CHIEF ADMINISTRATIVE OFFICER

  • Officer
0 2020-07-30 2

VIRGIN HERBERT EVP, RESEARCH & CSO

  • Officer
0 2020-07-28 10

PANG PHILLIP CHIEF MEDICAL OFFICER

  • Officer
15,777 2020-07-15 6

NISHAR DIPCHAND

  • Director
0 2020-07-15 2

HORN HOWARD CFO

  • Officer
177,777 2020-07-13 8

SIGAL CHARLES ELLIOTT

  • Director
0 2020-07-10 2

SHARP PHILLIP A

  • Director
0 2020-07-01 4

RAMASASTRY SAIRA

  • Director
0 2020-06-26 3

SATO VICKI L

  • Director
0 2020-06-25 3

NELSEN ROBERT

  • Director
0 2020-06-18 3

BUROW KRISTINA

  • Director
0 2020-06-18 3

PEREZ ROBERT J

  • Director
0 2020-05-21 3

MORE ROBERT J

  • Director
0 2020-05-21 5

SCANGOS GEORGE A

  • Director
738,312 2020-05-18 2

ARCH VENTURE PARTNERS IX, LLC

ARCH VENTURE PARTNERS IX, L.P.

ARCH VENTURE PARTNERS IX OVERAGE, L.P.

ARCH VENTURE FUND IX, L.P.

ARCH VENTURE FUND IX OVERAGE, L.P.

CRANDELL KEITH

BYBEE CLINTON

  • 10% Owner
8,243,039 2020-02-10 1

ABU DHABI INVESTMENT AUTHORITY

PLATINUM INTERNATIONAL INVESTMENT HOLDING RSC LTD

PLATINUM FALCON B 2018 RSC LTD

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
3,666,666 2019-10-16 2

BILL & MELINDA GATES FOUNDATION

2,777,777 2019-10-16 2

ALASKA PERMANENT FUND CORP

16,666,668 2019-10-16 2

FRUEH KLAUS

  • Director
440,621 2019-10-16 2

SVF ENDURANCE (CAYMAN) LTD

SB INVESTMENT ADVISERS (UK) LTD

SOFTBANK VISION FUND (AIV M1) L.P.

  • 10% Owner
22,616,666 2019-10-16 2

Q-VENTURES PROGRAM II (CO-INVEST HOLDINGS) LTD.

ANGELLA FRANK G.

QUINN CHRISTOPHER

  • FORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDER
1,666,666 2019-10-16 3

TEMASEK HOLDINGS (PRIVATE) LTD

FULLERTON MANAGEMENT PTE LTD

TEMASEK LIFE SCIENCES PRIVATE LTD

TLS BETA PTE. LTD.

V-SCIENCES INVESTMENTS PTE LTD

  • 10% Owner
5,499,999 2019-10-16 1

TLS BETA PTE. LTD.

TEMASEK LIFE SCIENCES PRIVATE LTD

FULLERTON MANAGEMENT PTE LTD

TEMASEK HOLDINGS (PRIVATE) LTD

  • 10% Owner
0 2019-10-10 1

KAMARCK MICHAEL E. CHIEF TECHNOLOGY OFFICER

  • Officer
166,666 2019-10-10 1

Q-VENTURES PROGRAM II (CO-INVEST HOLDINGS) LTD.

  • 10% Owner
0 2019-10-10 3

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

PARRISH JAY - Officer CHIEF BUSINESS OFFICER

2020-08-03 M 9,259 d 37,037 222,222.00 direct

PARRISH JAY - Officer CHIEF BUSINESS OFFICER

2020-08-03 M 9,259 $1.49 a 231,481 222,222.00 direct

PARRISH JAY - Officer CHIEF BUSINESS OFFICER

2020-08-03 S 11,110 $47.65 d 222,222 222,222.00 direct yes

PARRISH JAY - Officer CHIEF BUSINESS OFFICER

2020-08-03 M 1,851 d 60,184 222,222.00 direct

PARRISH JAY - Officer CHIEF BUSINESS OFFICER

2020-08-03 M 1,851 $1.58 a 233,332 222,222.00 direct

RICE STEVEN J. - Officer CHIEF ADMINISTRATIVE OFFICER

2020-07-30 A 40,000 a 40,000 0.00 direct

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-07-28 S 7,900 $47.99 d 0 0.00 direct yes

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-07-28 S 7,900 $47.99 d 0 0.00 direct yes

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-07-28 M 7,900 $1.53 a 7,900 0.00 direct

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-07-28 M 7,900 $1.53 a 7,900 0.00 direct

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-07-28 M 7,900 d 508,155 0.00 direct

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-07-28 M 7,900 d 508,155 0.00 direct

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-07-15 M 2,314 $5.18 a 28,277 15,777.00 direct

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-07-15 S 7,500 $49.52 d 15,777 15,777.00 direct yes

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-07-15 M 10,186 $1.58 a 25,963 15,777.00 direct

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-07-15 S 5,000 $49.54 d 23,277 15,777.00 direct yes

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-07-14 S 7,900 $48.85 d 0 0.00 direct yes

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-07-14 M 7,900 $1.53 a 7,900 0.00 direct

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-07-14 M 7,900 d 516,055 0.00 direct

HORN HOWARD - Officer CFO

2020-07-13 S 30,000 $50.06 d 177,777 177,777.00 direct yes

SIGAL CHARLES ELLIOTT - Director

2020-07-10 A 57,777 a 57,777 0.00 direct

HORN HOWARD - Officer CFO

2020-07-02 S 10,000 $40.00 d 207,777 207,777.00 direct yes

HORN HOWARD - Officer CFO

2020-07-01 S 400 $39.33 d 217,777 207,777.00 direct yes

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-07-01 M 9,722 d 76,338 15,777.00 direct

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-07-01 S 7,500 $37.79 d 23,277 15,777.00 direct yes

PARRISH JAY - Officer CHIEF BUSINESS OFFICER

2020-07-01 M 49,075 d 62,035 222,222.00 direct

PARRISH JAY - Officer CHIEF BUSINESS OFFICER

2020-07-01 M 49,075 $1.58 a 297,222 222,222.00 direct

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-07-01 M 10,186 d 98,147 15,777.00 direct

HORN HOWARD - Officer CFO

2020-07-01 S 500 $38.78 d 218,177 207,777.00 direct yes

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-07-01 M 2,778 d 108,333 15,777.00 direct

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-07-01 M 9,722 $5.18 a 28,277 15,777.00 direct

PARRISH JAY - Officer CHIEF BUSINESS OFFICER

2020-07-01 M 25,925 d 46,296 222,222.00 direct

PARRISH JAY - Officer CHIEF BUSINESS OFFICER

2020-07-01 M 25,925 $1.49 a 248,147 222,222.00 direct

HORN HOWARD - Officer CFO

2020-07-01 S 9,100 $37.72 d 218,677 207,777.00 direct yes

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-07-01 S 5,000 $37.77 d 15,777 15,777.00 direct yes

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-07-01 M 2,778 $1.58 a 18,555 15,777.00 direct

PARRISH JAY - Officer CHIEF BUSINESS OFFICER

2020-07-01 S 75,000 $37.95 d 222,222 222,222.00 direct yes

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-07-01 M 2,314 d 74,024 15,777.00 direct

HORN HOWARD - Officer CFO

2020-06-25 S 30,000 $50.00 d 227,777 227,777.00 direct yes

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-06-24 M 9,360 d 523,955 0.00 direct

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-06-24 M 9,360 $1.53 a 9,360 0.00 direct

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-06-24 S 9,360 $48.00 d 0 0.00 direct yes

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-06-23 M 5,560 d 533,315 0.00 direct

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-06-23 S 5,560 $38.99 d 0 0.00 direct yes

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-06-23 M 5,560 $1.53 a 5,560 0.00 direct

HORN HOWARD - Officer CFO

2020-06-19 S 10,000 $40.00 d 257,777 257,777.00 direct yes

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-06-19 S 1,755 $38.00 d 1,755 0.00 direct yes

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-06-19 M 3,510 d 538,875 0.00 direct

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-06-19 M 3,510 $1.53 a 3,510 0.00 direct

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-06-19 S 1,755 $38.00 d 0 0.00 direct yes

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-06-17 S 7,500 $37.26 d 15,777 15,777.00 direct yes

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-06-17 S 5,000 $37.27 d 23,277 15,777.00 direct yes

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-06-17 M 12,500 d 86,110 15,777.00 direct

PANG PHILLIP - Officer CHIEF MEDICAL OFFICER

2020-06-17 M 12,500 $5.18 a 28,277 15,777.00 direct

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-06-09 M 3,805 $1.53 a 3,805 0.00 direct

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-06-09 M 3,805 d 542,385 0.00 direct

VIRGIN HERBERT - Officer EVP, RESEARCH & CSO

2020-06-09 S 3,805 $36.28 d 0 0.00 direct yes
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments